Squarepoint Ops LLC Acquires 192,655 Shares of Maximus, Inc. $MMS

Squarepoint Ops LLC increased its holdings in Maximus, Inc. (NYSE:MMS) by 723.0% in the second quarter, Holdings Channel.com reports. The firm owned 219,301 shares of the health services provider’s stock after acquiring an additional 192,655 shares during the period. Squarepoint Ops LLC’s holdings in Maximus were worth $11,790,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Royal Bank of Canada lifted its stake in Maximus by 146.2% in the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after purchasing an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after buying an additional 11,754 shares during the period. Jane Street Group LLC lifted its stake in shares of Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after acquiring an additional 88,835 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Maximus in the 2nd quarter valued at about $204,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Performance

Shares of MMS stock opened at $56.05 on Thursday. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of 8.28 and a beta of 0.59. The stock has a fifty day moving average of $58.07 and a 200 day moving average of $62.56. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the firm earned $2.16 EPS. The company’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, research analysts expect that Maximus, Inc. will post 8.03 earnings per share for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.33 per share. The ex-dividend date was Friday, August 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.4%. Maximus’s payout ratio is currently 19.50%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MMS. Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a research report on Monday, August 17th. Finally, Zacks Research lowered Maximus from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Maximus currently has an average rating of “Reduce”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.